![]() |
Inclusion completed |
A phase 1, open label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic functionCancer type: Solide tumores Phase: I Principal Investigator: Sandstöm Per Country: SE Keywords: Sweden, panobinostat, solid tumors Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01007968?term=NCT01007968&rank=1 |